
DaVita Inc. – NYSE:DVA
DaVita stock price today
DaVita stock price monthly change
DaVita stock price quarterly change
DaVita stock price yearly change
DaVita key metrics
Market Cap | 12.37B |
Enterprise value | 19.21B |
P/E | 14.94 |
EV/Sales | 1.65 |
EV/EBITDA | 10.39 |
Price/Sales | 0.65 |
Price/Book | 10.71 |
PEG ratio | -0.34 |
EPS | 9.06 |
Revenue | 12.33B |
EBITDA | 2.48B |
Income | 815.63M |
Revenue Q/Q | 6.88% |
Revenue Y/Y | 5.76% |
Profit margin | 4.83% |
Oper. margin | 11.31% |
Gross margin | 29.29% |
EBIT margin | 11.31% |
EBITDA margin | 20.13% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDaVita stock price history
DaVita stock forecast
DaVita financial statements
Jun 2023 | 3.00B | 178.69M | 5.96% |
---|---|---|---|
Sep 2023 | 3.12B | 246.63M | 7.9% |
Dec 2023 | 3.14B | 150.66M | 4.79% |
Mar 2024 | 3.07B | 239.64M | 7.8% |
Sep 2025 | 3.29B | 304.82M | 9.24% |
---|---|---|---|
Oct 2025 | 3.33B | 281.44M | 8.43% |
Dec 2025 | 3.36B | 204.38M | 6.08% |
Mar 2026 | 3.27B | 241.19M | 7.36% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 16958845000 | 14.32B | 84.49% |
---|---|---|---|
Sep 2023 | 16928740000 | 14.10B | 83.31% |
Dec 2023 | 17619477000 | 14.87B | 84.43% |
Mar 2024 | 17430935000 | 14.79B | 84.88% |
Jun 2023 | 450.10M | -347.11M | -96.83M |
---|---|---|---|
Sep 2023 | 661.16M | -139.84M | -394.50M |
Dec 2023 | 486.75M | -171.33M | -401.76M |
Mar 2024 | -134.83M | -215.20M | 319.31M |
DaVita alternative data
DaVita Social Media Accounts
May 2025 | 22795 |
---|---|
Jul 2025 | 23223 |
Aug 2025 | 23510 |
Areas of Focus
12 Feb 2023 | 8 | 70 | 8 |
---|---|---|---|
19 Feb 2023 | 8 | 74 | 9 |
26 Feb 2023 | 8 | 69 | 9 |
5 Mar 2023 | 9 | 75 | 9 |
12 Mar 2023 | 9 | 74 | 9 |
19 Mar 2023 | 10 | 73 | 10 |
26 Mar 2023 | 9 | 75 | 10 |
2 Apr 2023 | 8 | 75 | 10 |
9 Apr 2023 | 9 | 75 | 9 |
16 Apr 2023 | 10 | 77 | 10 |
23 Apr 2023 | 10 | 76 | 10 |
30 Apr 2023 | 9 | 72 | 9 |
7 May 2023 | 10 | 72 | 9 |
14 May 2023 | 8 | 66 | 9 |
21 May 2023 | 8 | 74 | 10 |
28 May 2023 | 9 | 76 | 10 |
4 Jun 2023 | 8 | 68 | 8 |
11 Jun 2023 | 9 | 73 | 9 |
18 Jun 2023 | 9 | 72 | 10 |
25 Jun 2023 | 9 | 71 | 8 |
DaVita
12 Feb 2023 | 74 |
---|---|
19 Feb 2023 | 76 |
26 Feb 2023 | 62 |
5 Mar 2023 | 72 |
12 Mar 2023 | 72 |
19 Mar 2023 | 67 |
26 Mar 2023 | 68 |
2 Apr 2023 | 75 |
9 Apr 2023 | 75 |
16 Apr 2023 | 74 |
23 Apr 2023 | 69 |
30 Apr 2023 | 68 |
7 May 2023 | 71 |
14 May 2023 | 65 |
21 May 2023 | 71 |
28 May 2023 | 71 |
4 Jun 2023 | 57 |
11 Jun 2023 | 69 |
18 Jun 2023 | 68 |
25 Jun 2023 | 68 |
Davita Services
24 Nov 2024 | 4 | 38 |
---|---|---|
1 Dec 2024 | 5 | 37 |
8 Dec 2024 | 5 | 38 |
15 Dec 2024 | 5 | 37 |
22 Dec 2024 | 6 | 42 |
29 Dec 2024 | 6 | 39 |
5 Jan 2025 | 6 | 39 |
12 Jan 2025 | 6 | 65 |
19 Jan 2025 | 5 | 45 |
26 Jan 2025 | 6 | 40 |
2 Feb 2025 | 6 | 45 |
9 Feb 2025 | 5 | 42 |
16 Feb 2025 | 5 | 40 |
23 Feb 2025 | 4 | 35 |
2 Mar 2025 | 4 | 38 |
9 Mar 2025 | 5 | 42 |
16 Mar 2025 | 4 | 38 |
23 Mar 2025 | 6 | 43 |
30 Mar 2025 | 4 | 40 |
6 Apr 2025 | 4 | 39 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
Aug 2023 | 4,018 |
---|---|
Sep 2023 | 5,079 |
Oct 2023 | 4,522 |
Nov 2023 | 4,751 |
Dec 2023 | 4,178 |
Jan 2024 | 4,161 |
Feb 2024 | 4,232 |
Apr 2024 | 3,804 |
May 2024 | 3,981 |
Jun 2024 | 3,861 |
Jul 2024 | 3,728 |
Dec 2024 | 3,161 |
Jan 2025 | 3,533 |
Feb 2025 | 3,128 |
May 2025 | 3,169 |
Jul 2025 | 3,350 |
Aug 2025 | 3,822 |
Aug 2023 | 70,000 |
---|---|
Sep 2023 | 70,000 |
Oct 2023 | 70,000 |
Nov 2023 | 70,000 |
Dec 2023 | 70,000 |
Jan 2024 | 70,000 |
Feb 2024 | 70,000 |
Mar 2024 | 70,000 |
Apr 2024 | 70,000 |
May 2024 | 70,000 |
Jun 2024 | 70,000 |
Jul 2024 | 70,000 |
DaVita other data
Period | Buy | Sel |
---|---|---|
Feb 2024 | 0 | 141937 |
May 2024 | 0 | 5030 |
Aug 2024 | 0 | 158864 |
Sep 2024 | 0 | 59881 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | WATERS KATHLEEN ALYCE officer: Chief Le.. | Common Stock | 8,078 | $108.93 | $879,937 | ||
Option | WATERS KATHLEEN ALYCE officer: Chief Le.. | Common Stock | 8,078 | $108.93 | $879,937 | ||
Option | WATERS KATHLEEN ALYCE officer: Chief Le.. | Stock Appreciation Rights | 8,078 | $108.93 | $879,937 | ||
Option | WATERS KATHLEEN ALYCE officer: Chief Le.. | Stock Appreciation Rights | 8,078 | $108.93 | $879,937 | ||
Option | ACKERMAN JOEL officer: CFO and .. | Common Stock | 78,999 | $75.95 | $5,999,974 | ||
Option | ACKERMAN JOEL officer: CFO and .. | Common Stock | 78,999 | $75.95 | $5,999,974 | ||
Option | ACKERMAN JOEL officer: CFO and .. | Stock Appreciation Rights | 78,999 | $75.95 | $5,999,974 | ||
Option | ACKERMAN JOEL officer: CFO and .. | Stock Appreciation Rights | 78,999 | $75.95 | $5,999,974 | ||
Sale | RODRIGUEZ JAVIER director, officer.. | Common Stock | 50,000 | $165.05 | $8,252,500 | ||
Sale | RODRIGUEZ JAVIER director, officer.. | Common Stock | 9,881 | $162.85 | $1,609,121 |
Quarter | Transcript |
---|---|
Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 13 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
DaVita: International Expansion And Buybacks Will Boost Returns
DaVita: Simple And Compelling After Sell-Off
Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Renalytix: Commercializing First AI Kidney Disease Diagnostic Tool
DaVita: Valuations, Forward Growth Unsupportive Of Buy
DaVita: High Debt Load, And Increased Interest Expenses
DaVita: Earnings Top Lowered Expectations, Labor Costs A Concern, Cautious Chart
Betting On Biotech
-
What's the price of DaVita stock today?
One share of DaVita stock can currently be purchased for approximately $136.8.
-
When is DaVita's next earnings date?
Unfortunately, DaVita's (DVA) next earnings date is currently unknown.
-
Does DaVita pay dividends?
No, DaVita does not pay dividends.
-
How much money does DaVita make?
DaVita has a market capitalization of 12.37B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.57% to 12.14B US dollars.
-
What is DaVita's stock symbol?
DaVita Inc. is traded on the NYSE under the ticker symbol "DVA".
-
What is DaVita's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of DaVita?
Shares of DaVita can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are DaVita's key executives?
DaVita's management team includes the following people:
- Mr. Javier J. Rodriguez Chief Executive Officer & Executive Director(age: 54, pay: $4,940,000)
- Mr. Michael David Staffieri Chief Operating Officer of Kidney Care(age: 51, pay: $2,880,000)
- Mr. Joel Ackerman Chief Financial Officer & Treasurer(age: 60, pay: $2,010,000)
- Ms. Kathleen Alyce Waters Chief Legal and Public Affairs Officer(age: 57, pay: $1,500,000)
- Mr. James O. Hearty Chief Compliance Officer(age: 56, pay: $1,070,000)
-
How many employees does DaVita have?
As Jul 2024, DaVita employs 70,000 workers.
-
When DaVita went public?
DaVita Inc. is publicly traded company for more then 29 years since IPO on 31 Oct 1995.
-
What is DaVita's official website?
The official website for DaVita is davita.com.
-
Where are DaVita's headquarters?
DaVita is headquartered at 2000 16th Street, Denver, CO.
-
How can i contact DaVita?
DaVita's mailing address is 2000 16th Street, Denver, CO and company can be reached via phone at +7 206312100.
DaVita company profile:

DaVita Inc.
davita.comNYSE
70,000
Medical - Care Facilities
Healthcare
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Denver, CO 80202
CIK: 0000927066
ISIN: US23918K1088
CUSIP: 23918K108